A. Yazici Et Al. , "The Frequency and Clinical Significance of IgA Anticardiolipin and Anti-beta 2-Glycoprotein-I Antibodies in Antiphospholipid Antibody Patients with and without Lupus," ARTHRITIS & RHEUMATOLOGY , vol.68, 2016
Yazici, A. Et Al. 2016. The Frequency and Clinical Significance of IgA Anticardiolipin and Anti-beta 2-Glycoprotein-I Antibodies in Antiphospholipid Antibody Patients with and without Lupus. ARTHRITIS & RHEUMATOLOGY , vol.68 .
Yazici, A., Unlu, O., Chighizola, C. B., Erkan, D., & Petri, M., (2016). The Frequency and Clinical Significance of IgA Anticardiolipin and Anti-beta 2-Glycoprotein-I Antibodies in Antiphospholipid Antibody Patients with and without Lupus. ARTHRITIS & RHEUMATOLOGY , vol.68.
Yazici, AYTEN Et Al. "The Frequency and Clinical Significance of IgA Anticardiolipin and Anti-beta 2-Glycoprotein-I Antibodies in Antiphospholipid Antibody Patients with and without Lupus," ARTHRITIS & RHEUMATOLOGY , vol.68, 2016
Yazici, AYTEN Et Al. "The Frequency and Clinical Significance of IgA Anticardiolipin and Anti-beta 2-Glycoprotein-I Antibodies in Antiphospholipid Antibody Patients with and without Lupus." ARTHRITIS & RHEUMATOLOGY , vol.68, 2016
Yazici, A. Et Al. (2016) . "The Frequency and Clinical Significance of IgA Anticardiolipin and Anti-beta 2-Glycoprotein-I Antibodies in Antiphospholipid Antibody Patients with and without Lupus." ARTHRITIS & RHEUMATOLOGY , vol.68.
@article{article, author={AYTEN YAZICI Et Al. }, title={The Frequency and Clinical Significance of IgA Anticardiolipin and Anti-beta 2-Glycoprotein-I Antibodies in Antiphospholipid Antibody Patients with and without Lupus}, journal={ARTHRITIS & RHEUMATOLOGY}, year=2016}